Because these three ICPRGs have the potential to be novel actionable targets in cancer therapy, we further examined these individual genes by Box and Whisker plots of log2 FPKM expression levels in IFNγ positive and negative tumors of CRC, SKCM, BC, ESC, STC, and LUSC. The gene discussed is IFNG; the disease is colorectal carcinoma.